Navigation Links
Prostate Cancer Therapy may Increase Risk of Death in Older Patients

Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease// in patients over age 65, according to a new study.

The study results were based on data from CaPSURE, a national registry of men with prostate cancer. Although the findings need to be confirmed in clinical trials, the study authors state that oncologists should weigh the benefits of androgen deprivation therapy, or ADT, against the risk of heart problems in older prostate cancer patients.

The goal of ADT is to block the level of circulating androgens (male hormones), which can fuel the growth of prostate cancers. "Androgen deprivation therapy is associated with elevated body mass index, increased body fat deposits and diabetes, all of which raise the risk of death from heart diseased," explains the study's lead author, Henry Tsai, MD, a resident physician at Dana-Farber, Brigham and Women's and the Harvard Radiation Oncology Program.

"Although our findings demonstrated that older men receiving this treatment may be at increased risk, even after taking into account other cardiovascular risk factors, a prospective clinical trial would be needed to confirm a cause-and-effect relationship."

Drawing on the CaPSURE database, Tsai and his colleagues compared the number of cardiac-related deaths among 735 men with localized prostate cancer who received ADT and among 2,901 men with the disease whose treatment did not include ADT.

After factoring in other known risks for cardiovascular disease (such as diabetes, hypertension, body mass index and smoking), researchers found that the longer patients received ADT, the sooner they were likely to die from heart disease. When the researchers analyzed the data by patients' age, the link between ADT use and death from heart disease was significant in patients over age 65, but not in those under 65. After five years, 3 percent of older me n who received androgen deprivation therapy died of cardiac causes, compared with only 0.9 percent of men who did not receive the therapy.

"These findings should help oncologists determine which older patients are the best candidates for ADT," Tsai remarks. "If a patient is at high risk of cardiovascular disease, it would be advisable for an oncologist to discuss the pros and cons of ADT treatment with him before proceeding on a course of treatment."

Source-Eurekalert
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is a fascinating ... and move the readers one step closer to God. “Psalms of Humidity” is the ... mistakes that have been made within his life are the very same things that ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... the Brazilian jiu-jitsu community have raised more than $15,000 in just a couple ... in professional submission grappling matches and world-class instructor seminars, organizers expect to double ...
(Date:9/19/2017)... ... September 19, 2017 , ... Peter Chandonait, Abt Associates ... Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , has been named ... Innovation to Action Award, a USAID Catalyst Award, recognizes USAID staff and implementing ...
(Date:9/19/2017)... Texas (PRWEB) , ... September 19, 2017 , ... MelaKids, ... body’s own blue light filter. When we’re born, Nature gives us a full ... But with age, we continuously lose this natural glare-reducing pigment; however, around the ...
(Date:9/19/2017)... Va (PRWEB) , ... September 19, 2017 , ... The ... the use of health IT to create efficiencies in healthcare information exchange and a ... the release of their latest industry white paper, entitled Barriers to Adoption of ...
Breaking Medicine News(10 mins):
(Date:8/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will present at the ... in New York . John Greisch ... present at 11:05 a.m. Eastern Time. The ... A recorded replay will be available one hour after the ... About Hill-Rom Holdings, Inc. ...
(Date:8/25/2017)... , Aug. 25, 2017  Innovation Zed ( www.innovationzed.com ), an ... NHS in South Yorkshire and Bassetlaw, ... pen accessory used with diabetes patients as part of a national NHS ... ... InsulCheck Connect, a snap-on accessory for ...
(Date:8/24/2017)... Aug. 24, 2017 BioBridges, a Career Portfolio® ... community, is excited to announce its corporate sponsorship of ... (BoBB). Proceeds from the event will benefit charitable foundations ... "BioBridges is delighted to return once again as ... Bands ," said Jason Falchuk , BioBridges Founding ...
Breaking Medicine Technology: